Skip to main content

Home/ Health Now/ Group items tagged Crucell

Rss Feed Group items tagged

Matti Narkia

Crucell's Revolutionary Antibody for Universal Therapy Against Flu - 0 views

  •  
    Leiden, The Netherlands (February 26, 2009) - Dutch biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) announces that the journal Science today published a study showing why Crucell's novel anti-influenza antibody is so effective against such a broad range of influenza virus subtypes. These characteristics make the Crucell antibody CR6261 a potentially revolutionary therapy against seasonal and pandemic flu.
Matti Narkia

Second team finds natural super flu fighter - 0 views

  •  
    WASHINGTON, Feb 26 (Reuters) - An antibody being developed by a Dutch drug company chokes off both seasonal flu and the H5N1 avian flu virus and might offer a way to develop better treatments and vaccines, researchers reported on Thursday.
1 - 2 of 2
Showing 20 items per page